Singh Shivendra V, Choi Sunga, Zeng Yan, Hahm Eun-Ryeong, Xiao Dong
Department of Pharmacology and Urology and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Cancer Res. 2007 Aug 1;67(15):7439-49. doi: 10.1158/0008-5472.CAN-07-0120.
Guggulsterone, a constituent of Indian Ayurvedic medicinal plant Commiphora mukul, causes apoptosis in cancer cells but the sequence of events leading to cell death is poorly understood. We now show that guggulsterone-induced cell death in human prostate cancer cells is caused by reactive oxygen intermediate (ROI)-dependent activation of c-Jun NH(2)-terminal kinase (JNK). Exposure of PC-3 and LNCaP cells to apoptosis inducing concentrations of guggulsterone resulted in activation of JNK and p38 mitogen-activated protein kinase (p38 MAPK) in both cell lines and activation of extracellular signal-regulated kinase 1/2 (ERK1/2) in LNCaP cells. The guggulsterone-induced apoptosis in PC-3/LNCaP cells was partially but statistically significantly attenuated by pharmacologic inhibition (SP600125) as well as genetic suppression of JNK activation. On the other hand, pharmacologic inhibition of p38 MAPK activation in PC-3 or LNCaP cells (SB202190) and ERK1/2 activation in LNCaP cells (PD98059) did not protect against guggulsterone-induced cell death. The guggulsterone treatment caused generation of ROI in prostate cancer cells but not in a normal prostate epithelial cell line (PrEC), which was also resistant to guggulsterone-mediated JNK activation. The guggulsterone-induced JNK activation as well as cell death in prostate cancer cells was significantly attenuated by overexpression of catalase and superoxide dismutase. In addition, guggulsterone treatment resulted in a decrease in protein level and promoter activity of androgen receptor in LNCaP cells. In conclusion, the present study reveals that the guggulsterone-induced cell death in human prostate cancer cells is regulated by ROI-dependent activation of JNK and guggulsterone inhibits promoter activity of androgen receptor.
古古甾酮是印度阿育吠陀药用植物没药树的一种成分,可导致癌细胞凋亡,但导致细胞死亡的一系列事件却鲜为人知。我们现在表明,古古甾酮诱导人前列腺癌细胞死亡是由活性氧中间体(ROI)依赖性激活c-Jun氨基末端激酶(JNK)引起的。将PC-3和LNCaP细胞暴露于诱导凋亡浓度的古古甾酮后,两种细胞系中的JNK和p38丝裂原活化蛋白激酶(p38 MAPK)均被激活,而LNCaP细胞中的细胞外信号调节激酶1/2(ERK1/2)被激活。通过药理学抑制(SP600125)以及JNK激活的基因抑制,古古甾酮诱导的PC-3/LNCaP细胞凋亡得到部分但具有统计学意义的减弱。另一方面,PC-3或LNCaP细胞中p38 MAPK激活的药理学抑制(SB202190)以及LNCaP细胞中ERK1/2激活的药理学抑制(PD98059)并不能预防古古甾酮诱导的细胞死亡。古古甾酮处理导致前列腺癌细胞中产生ROI,但在正常前列腺上皮细胞系(PrEC)中未产生,PrEC对古古甾酮介导的JNK激活也具有抗性。过氧化氢酶和超氧化物歧化酶的过表达显著减弱了古古甾酮诱导的前列腺癌细胞中JNK激活以及细胞死亡。此外,古古甾酮处理导致LNCaP细胞中雄激素受体的蛋白水平和启动子活性降低。总之,本研究表明,古古甾酮诱导的人前列腺癌细胞死亡受ROI依赖性JNK激活的调节,且古古甾酮抑制雄激素受体的启动子活性。